Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dmitry Aleksandrovich Shvyrev"'
Autor:
Elena V. Filatova, Alexey N. Shevchenko, Viktor K. Khvan, Irina A. Khomutenko, Lyubov I. Belyakova, Dmitry Aleksandrovich Shvyrev, Elena S. Bondarenko, Oksana G. Shulgina, Aleksandr B. Sagakyants
Publikováno v:
Journal of Clinical Oncology. 39:e16508-e16508
e16508 Background: Bladder cancer (BC), which accounts for 4.5% of the total cancer incidence, is the cause of frequent severe disability and a significant deterioration in the quality of life of patients. BC development is determined by a number of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63a1405c3f2473456e297f9c9c9e6de9
https://doi.org/10.1200/jco.2021.39.15_suppl.e16508
https://doi.org/10.1200/jco.2021.39.15_suppl.e16508
Autor:
Dmitry Aleksandrovich Shvyrev, E.A. Lukbanova, Ekaterina V. Zaikina, Evgeniy A. Gusakov, D. V. Khodakova, Yuriy A. Sayapin, Yuriy N. Lazutin, Irina A. Khomutenko, M. V. Mindar, Alexey N. Shevchenko, Anna S. Goncharova, Elena V. Filatova, A. V. Volkova
Publikováno v:
Journal of Clinical Oncology. 39:e15008-e15008
e15008 Background: Lung cancer is the most common cancer worldwide. The efficacy of chemotherapy for this tumor does not exceed 40%. Moreover, all cytotoxic agents cause many side effects. The search for new substances with an antitumor effect seems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc452404b63f7055a294c6565b385745
https://doi.org/10.1200/jco.2021.39.15_suppl.e15008
https://doi.org/10.1200/jco.2021.39.15_suppl.e15008
Autor:
Elena V. Filatova, Viktor K. Khvan, Irina A. Khomutenko, Inna Arnoldovna Novikova, Elena S. Bondarenko, Dmitry Aleksandrovich Shvyrev, Aleksandr B. Sagakyants, Elena P. Ulianova, Alexey N. Shevchenko, Lyubov I. Belyakova
Publikováno v:
Journal of Clinical Oncology. 39:e16511-e16511
e16511 Background: Bladder cancer (BC) is an urgent problem of oncology in the world, and without appropriate and timely treatment it can lead to severe disability and a significant deterioration in the quality of life of patients. BC accounts for 4.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abd9b272014ad76f00dc6bdac8e7674f
https://doi.org/10.1200/jco.2021.39.15_suppl.e16511
https://doi.org/10.1200/jco.2021.39.15_suppl.e16511
Autor:
Sergey N Dimitriadi, Ekaterina P. Omelchuk, A. D. Rozenko, Dmitry A. Rozenko, A. Velichko, Aleksandr V. Faenson, Oleg I. Kit, Elena M. Frantsiyants, Dmitry Aleksandrovich Shvyrev, Elena V. Filatova
Publikováno v:
Journal of Clinical Oncology. 37:e16108-e16108
e16108 Background: The specialists consider partial nephrectomy (PN) under warm ischemia (WI) as a standard treatment option for localized renal cell carcinoma (RCC) patients. However, clinical use of the method is restricted by acute kidney injury (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ae5ee124e54f5cff3be5abb78c8bd98
https://doi.org/10.1200/jco.2019.37.15_suppl.e16108
https://doi.org/10.1200/jco.2019.37.15_suppl.e16108
Autor:
Oleg I. Kit, Elena M. Frantsiyants, Aleksandr V. Faenson, Dmitry Aleksandrovich Shvyrev, Natalya Dmitrievna Ushakova, Sergey N Dimitriadi, Dmitry A. Rozenko, Sergey I. Goncharov
Publikováno v:
Journal of Clinical Oncology. 35:e16077-e16077
e16077 Background: Introduction of modern organ-preservingapproaches in surgical treatment of kidney cancer is limited by the duration of warm ischemia used during the partial nephrectomy (PN), including surgery for elective indications. Some resecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45576b33d30b0372a5f15ad4c6406998
https://doi.org/10.1200/jco.2017.35.15_suppl.e16077
https://doi.org/10.1200/jco.2017.35.15_suppl.e16077
Autor:
Yulia A. Pogorelova, Dmitry Aleksandrovich Shvyrev, Alexey N. Shevchenko, Margarita Kozlova, Elena M. Frantsiyants, Lyudmila Gennadiyevna Sergostyants, Ayna Mayerbekovna Salatova
Publikováno v:
Journal of Clinical Oncology. 33:e15608-e15608
e15608 Background: Neoplasms are similar in their damaging effect on metabolic processes, and study of the effect of primary and metastatic tumors on an organism is an important aspect of the probl...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3259c458096e7663abae9e44ee3d2f9
https://doi.org/10.1200/jco.2015.33.15_suppl.e15608
https://doi.org/10.1200/jco.2015.33.15_suppl.e15608
Autor:
Andrey Vladimirovich Bakhtin, Elena P. Ulianova, Dmitry Aleksandrovich Shvyrev, Rukiyat Isaeva, Aleksey Yurievich Maksimov, Inna Arnoldovna Novikova, Elena N. Chernikova, Olesya N. Selyutina, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 33:e22017-e22017
e22017 Background: The purpose of this study was to analyze the content and detection rate of CTCs in blood of patients with kidney, prostate, breast, lung and colon cancers. Methods: 187 patients ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c27a1d7f4a4a30e55c52ba8b480aa81
https://doi.org/10.1200/jco.2015.33.15_suppl.e22017
https://doi.org/10.1200/jco.2015.33.15_suppl.e22017
Autor:
Alexey N. Shevchenko, Mikhail V. Tarakanov, Dmitry Aleksandrovich Shvyrev, Aleksandr V. Faenson, Andrey Vladimirovich Bakhtin, Sergey G. Seleznev, Oleg I. Kit, Inna Arnoldovna Novikova, Sergey N Dimitriadi, Olesya N. Selyutina, Irina A. Khomutenko
Publikováno v:
Journal of Clinical Oncology. 33:e22019-e22019
e22019 Background: The purpose of the study was to evaluate quantitatively CTCs in peripheral blood of patients with stage III-IV prostate cancer. Methods: 30 patients with systemic prostate cancer...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d77fa54e78753bec28389bbf275f436
https://doi.org/10.1200/jco.2015.33.15_suppl.e22019
https://doi.org/10.1200/jco.2015.33.15_suppl.e22019